Predict your next investment

MOBILE & TELECOMMUNICATIONS | RFID Systems
awarepoint.com

See what CB Insights has to offer

Executives

30

Board of Directors

7

AwarePoint Board of Directors

7 Board of directors

AwarePoint has 7 board of directors, including Brandon Hull.

Name

Firm

Work History

Other Seats

Brandon Hull

athenahealth, CodeRyte, Ivenix, Nexcura, Replication Medical, and Vitals

Brian Ascher

Adify, Atrenta, DATAllegro, Inrix, Intercasting Corporation, Martini Media Network, Personal Capital, RelayHealth, Retail Solutions, SmartBiz Loans, SocialShield, Vocera Communications, Winery Exchange, and WisdomArk

Dana Mead

Dana Mead joined Kleiner Perkins Caufield & Byers in May 2005 to work in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, ATI, Awarepoint, Inspire Medical Systems, Intersect ENT [Nasdaq: XENT], Pulmonx, Spiracur, and Teladoc [NYSE: TDOC]. For the past 30 years, Dana’s career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 12 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]), Corventis (acquired by Medtronic [NYSE:MDT]), Navigenics (acquired by Life Technologies Corp. [Nasdaq: LIFE]), Invuity [Nasdaq:IVTY], Spinal Modulation (Acquired by St. Jude Medical [NYSE: STJ], and OtisMed (acquired by Stryker [Nasdaq: SYK]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and he is the former chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.

Intersect ENT, Invuity, PulmonX, Spinal Modulation, Teladoc Health, and Voyage Medical

Jay Deady

President & CEO, Awarepoint; EVP, Client Solutions, Eclipsys; SVP, McKesson; SVP & GM, ADAC Labs Healthcare Information Solutions; VP, Regional Marketing, Cerner Corp.

Recondo Technology

Nicolas Nierenberg

Name

Brandon Hull

Brian Ascher

Dana Mead

Jay Deady

Nicolas Nierenberg

Firm

Work History

Dana Mead joined Kleiner Perkins Caufield & Byers in May 2005 to work in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, ATI, Awarepoint, Inspire Medical Systems, Intersect ENT [Nasdaq: XENT], Pulmonx, Spiracur, and Teladoc [NYSE: TDOC]. For the past 30 years, Dana’s career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 12 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]), Corventis (acquired by Medtronic [NYSE:MDT]), Navigenics (acquired by Life Technologies Corp. [Nasdaq: LIFE]), Invuity [Nasdaq:IVTY], Spinal Modulation (Acquired by St. Jude Medical [NYSE: STJ], and OtisMed (acquired by Stryker [Nasdaq: SYK]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and he is the former chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.

President & CEO, Awarepoint; EVP, Client Solutions, Eclipsys; SVP, McKesson; SVP & GM, ADAC Labs Healthcare Information Solutions; VP, Regional Marketing, Cerner Corp.

Other Seats

athenahealth, CodeRyte, Ivenix, Nexcura, Replication Medical, and Vitals

Adify, Atrenta, DATAllegro, Inrix, Intercasting Corporation, Martini Media Network, Personal Capital, RelayHealth, Retail Solutions, SmartBiz Loans, SocialShield, Vocera Communications, Winery Exchange, and WisdomArk

Intersect ENT, Invuity, PulmonX, Spinal Modulation, Teladoc Health, and Voyage Medical

Recondo Technology

AwarePoint Management Team

30 Team Members

AwarePoint has 30 executives. AwarePoint's founder is James Adams. AwarePoint's current Chief Executive Officer, President is Timothy Roche.

Name

Work History

Title

Status

Timothy Roche

Chief Executive Officer, President

Current

Carla Gallegos

Executive Vice President

Current

Gary Jorgenson

Senior Vice President

Current

Thomas Warlan

Senior Vice President

Current

James Adams

Founder

Former

Name

Timothy Roche

Carla Gallegos

Gary Jorgenson

Thomas Warlan

James Adams

Work History

Title

Chief Executive Officer, President

Executive Vice President

Senior Vice President

Senior Vice President

Founder

Status

Current

Current

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.